Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 141,517 | 126,669 | 110,403 | 115,082 | 103,501 |
| Cost of Goods | 13,279 | 11,261 | 13,567 | 11,324 | 9,946 |
| Gross Profit | 128,238 | 115,408 | 96,836 | 103,758 | 93,555 |
| Operating Expenses | 106,858 | 100,702 | 125,124 | 107,774 | 111,524 |
| Operating Income | 21,659 | 14,967 | -27,721 | -3,692 | -17,023 |
| Interest Expense | 12,692 | 12,512 | 12,436 | 12,827 | 12,986 |
| Other Income | -2,182 | -2,347 | -3,426 | -15,141 | 5,304 |
| Pre-tax Income | 6,785 | 108 | -43,583 | -31,660 | -24,705 |
| Income Tax | 13,514 | 15,805 | 4,836 | 2,183 | -3,128 |
| Net Income Continuous | -6,729 | -15,697 | -48,419 | -33,843 | -21,577 |
| Net Income | $-6,729 | $-15,697 | $-48,419 | $-33,843 | $-21,577 |
| EPS Basic Total Ops | -0.02 | -0.05 | -0.16 | -0.11 | -0.07 |
| EPS Basic Continuous Ops | -0.02 | -0.05 | -0.16 | -0.11 | -0.07 |
| EPS Diluted Total Ops | -0.02 | -0.05 | -0.16 | -0.11 | -0.07 |
| EPS Diluted Continuous Ops | -0.02 | -0.05 | -0.16 | -0.11 | -0.07 |
| EPS Diluted Before Non-Recurring Items | 0.04 | 0.01 | -0.02 | N/A | N/A |
| EBITDA(a) | $24,403 | $17,709 | $-25,036 | $-974 | $-14,074 |